Skip to main content
. 2016 Jan;37(1):108–113. doi: 10.3174/ajnr.A4481

Table 2:

Postprocedural clinical outcomes by genotype groupsa

Group 1 (n = 44) Group 2 (n = 31) Group 3 (n = 28) Group 4 (n = 5) Fisher Exact Test, P Value
Ischemic complication (No.) (%) 5 (11.4) 3 (9.7) 9 (32.1) 1 (20.0) .08
Hemorrhagic complication (No.) (%) 8 (18.2) 1 (3.2) 5 (17.9) 2 (40.0) .06
mRS ≥2 (No.) (%) 5 (11.4) 1 (3.2) 2 (7.1) 1 (20.0) .35
a

Group 1: CYP2C19*1/*1; Group 2: CYP2C19*1/*2,*1/*3, *2/*2, *2/*3; Group 3: CYP2C19*1/*17,*17/*17; Group 4: CYP2C19*2/*17.